Corvus Pharmaceuticals, Inc. (CRVS)
15.88
+0.08
(+0.54%)
USD |
NASDAQ |
Mar 09, 16:00
15.88
0.00 (0.00%)
After-Hours: 19:39
Corvus Pharmaceuticals SG&A Expense (TTM) : 9.105M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 2.70B |
| Plus Therapeutics, Inc. | 11.09M |
| Geron Corp. | 159.26M |
| Jaguar Health, Inc. | 27.29M |
| Krystal Biotech, Inc. | 146.91M |